• SENSEX 81,583.30
    -212.85 (--0.26%)
  • BANKNIFTY 55,714.15
    -230.75 (--0.41%)
  • Vishal Mega Mart
    129.95 134.50(%)
  • Reliance Industr
    1,425.80 1,115.55(%)
  • Infosys
    1,647.70 2,006.80(%)
  • Sterlite Tech.
    119.00 109.09(%)
  • HDFC Bank
    1,919.55 1,588.50(%)
  • Varun Beverages
    469.50 419.40(%)
  • ICICI Bank
    1,417.60 1,101.00(%)
  • TCS
    3,522.30 4,585.90(%)
  • Happiest Minds
    674.00 955.00(%)
  • Mazagon Dock
    3,342.85 3,778.00(%)
  • Garden Reach Sh.
    3,205.00 3,528.00(%)
  • Bharti Airtel
    1,847.50 1,373.05(%)
  • M & M
    2,993.70 2,360.45(%)
  • Kotak Mah. Bank
    2,129.90 1,679.10(%)
  • Tata Motors
    672.00 542.55(%)
  • Cochin Shipyard
    2,244.10 2,977.10(%)
  • Hind. Unilever
    2,334.10 3,034.50(%)
  • Sun Pharma.Inds.
    1,641.40 1,461.40(%)
  • St Bk of India
    790.75 679.65(%)
  • HCL Technologies
    1,738.00 2,011.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Valiant Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 79218.0
  • ISIN : INE0JWS01017
113.58 -2 (-1.71%)
  • As on 17 Jun 2025 (EOD)
  • Today’s Low

    113.16
  • Today’s High

    118.00
  • Open

    117.00
  • Perv Close

    115.56
  • 52W Low

    75.20
  • 52W High

    157.49

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    493.51

  • Div & Yield %

    0.00

  • Book Value(₹)

    53.94

  • Debt-Equity Ratio

    -1.71

  • AGM Date

    17-Jun-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.41

  • Mar.Cap (₹Cr.)

    493.51

  • RONW (%)

    -1.71

  • ROCE (%)

    -1.63

Score Board

  • Equity (₹ in Cr.)

    43.45

  • BV (₹)

    53.90

  • Sales( ₹ in Cr.)

    133.36

  • NP (in Cr.)

    -2.15

  • NP Var(%)

    25.0

  • Div%

    0.0

  • CPS (₹)

    0.00

  • EPS (₹)

    -0.50

  • Traded Value (₹ in Lakhs)

    504.67

  • 52 Week High

    157.49

  • 52 Week Low

    75.20

  • Price BSE

    116.0

  • Price NSE

    116.00

  • Market Capital( in Cr.)

    504.67

  • P/C Ratio

    -4,012.90

  • P/E Ratio

    -234.40

  • Price Vs.BV

    -0.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 182.05 333.91 291.52 182.37 - -
Excise Duty 0.00 0.00 0.00 0.00 - -
Net Sales 182.05 333.91 291.52 182.37 - -
Other Income 9.68 4.86 1.95 1.41 - -
Stock Adjustments 1.14 0.24 1.97 0.13 - -
Total Income 192.87 339.01 295.44 183.91 - -
EXPENDITURE :            
Raw Materials 168.66 276.76 236.19 120.53 - -
Power and Fuel Cost 8.33 7.37 4.38 3.17 - -
Employee Cost 4.31 4.61 3.06 2.71 - -
Other Manufacturing Expenses 6.07 4.86 3.70 3.55 - -
Selling and Administration Expenses 2.76 4.09 2.76 2.25 - -
Miscellaneous Expenses 1.46 1.37 1.09 0.29 - -
Employee Benefit Expenses 4.31 4.61 3.06 2.71 - -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 - -
Total Expenses 191.59 299.06 251.18 132.50 - -
Operating Profit 1.28 39.95 44.26 51.41 - -
Interest 0.08 0.25 0.07 1.78 - -
Gross Profit 1.20 39.70 44.19 49.63 - -
Depreciation 1.95 1.56 2.49 2.61 - -
Profit Before Tax -0.75 38.14 41.70 47.02 - -
Current Tax -0.98 8.80 14.47 16.46 - -
Fringe Benefit tax 0.00 0.00 0.00 0.00 - -
Deferred Tax -0.11 0.34 -0.26 -0.03 - -
Reported Net Profit 0.34 29.00 27.50 30.59 - -
Extraordinary Items 3.20 0.00 0.03 0.00 - -
Adjusted Net Profit -2.86 29.00 27.47 30.59 - -
Adjustment below Net Profit 0.18 0.03 -48.92 19.37 - -
P & L Balance brought forward 51.59 22.56 78.08 28.12 - -
Statutory Appropriations 0.00 0.00 0.00 0.00 - -
Appropriations 0.00 0.00 34.10 0.00 - -
P & L Balance carried down 52.11 51.59 22.56 78.08 - -
Dividend 0.00 0.00 0.00 0.00 - -
Preference Dividend 0.00 0.00 0.00 0.00 - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 - -
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 - -
Earnings Per Share-Unit Curr 0.08 8.91 16.89 29.14 - -
Earnings Per Share(Adj)-Unit Curr 0.08 - - - - -
Book Value 54.52 30.86 43.89 84.36 - -
Book Value(Adj)-Unit Curr 54.52 - - - - -

Shareholding Pattern

  • Promoter Group

    74.94%

  • Public Share Holding

    25.06%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 12,211,000 28.10 12,211,000 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 32,561,000 74.94 32,561,000 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 278,686 0.64 278,686 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 278,686 0.64 278,686 3
2] Non Institution
Bodies Corporate 2,962,541 6.82 2,962,541 66
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 70,639 0.16 70,639 91
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 472,612 1.09 472,612 530
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,584,251 5.95 2,584,251 34
Individuals holding nominal share capital up to Rs. 1 lakh 4,491,531 10.34 4,491,531 14,296
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 10,610,314 24.42 10,610,314 15,025
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 43,450,000 100.00 43,450,000 15,036

Company Background

Valiant Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Valiant Laboratories Ltd
  • BSE Code : 79218.0
  • ISIN : INE0JWS01017
  • Incorporation Year

    2021

  • Registered Office

    104 Udyog Kshetra Mulund
    Goregaon Link Rd Mulund West, Mumbai,
    Maharashtra-400080

  • Telephone

    +91 22 49712001

  • FAX

  • Chairman

  • Managing Director

    Santosh S. Vora

  • Company Secretary

    Prajakta Patil

  • Auditor

    Raman S Shah & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Valiant Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Valiant Laborato 113.30 191.73 182.05 -231.22 -1.68
Abbott India 31,803.35 6,097.18 5,848.91 47.78 44.71
Astrazeneca Phar 10,081.60 1,330.33 1,295.53 217.75 33.26
P & G Health Ltd 5,907.05 1,166.89 1,151.26 39.04 39.76
Glaxosmi. Pharma 3,252.30 3,866.05 3,723.49 59.95 58.72
Cipla 1,503.50 17,645.00 16,574.34 23.54 20.10
Amrutanjan Healt 708.25 437.58 421.23 40.29 20.84
Guj. Themis Bio. 337.05 174.19 169.82 75.23 44.82
Fermenta Biotec. 334.25 315.24 307.09 14.55 4.10
Bliss GVS Pharma 141.95 638.96 605.46 21.67 11.19
Ambalal Sarabhai 36.76 11.70 3.81 34.04 1.92